Rus En Es
Main / Portfolio / Neurology. Psychiatry / Dementia in Alzheimer’s disease

Dementia in Alzheimer’s disease

GEROPHARM pays considerable attention to the regulation of drug safety. Currently, the company has the pharmacovigilance system which functions in accordance with international requirements and regulatory requirements for the Russian Federation. Employees collect data on the found adverse reactions that occur when taking medicinal preparations, the marketing authorization holder of which is GEROPHARM.



You are a health care professional?

Go up